Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC
Open Label Extension Study to evaluate long term safety and persistence of effect of A4250 in children with PFIC.
Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC
- 29 Janvier 2025 - 1 mn de lecture
Open Label Extension Study to evaluate long term safety and persistence of effect of A4250 in children with PFIC.
En rapport Clinical Trials
29 Janvier 2025
1 mn de lecture
Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot...
29 Janvier 2025
1 mn de lecture
Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis
29 Janvier 2025
1 mn de lecture
Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET
29 Janvier 2025
1 mn de lecture
Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly
29 Janvier 2025
1 mn de lecture
Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg
29 Janvier 2025
1 mn de lecture
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients
29 Janvier 2025
1 mn de lecture
Efficacy and Safety of Lanreotide Autogel (ATG) in Combination With Temozolomide in Subjects With Thoracic Neuroendocrine Tumors.
29 Janvier 2025
1 mn de lecture
Quality of Life in Patients With Inoperable Malignant Bowel Obstruction
29 Janvier 2025
1 mn de lecture
Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours
29 Janvier 2025
1 mn de lecture